These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 3534744

  • 1. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [Abstract] [Full Text] [Related]

  • 3. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D, Le Noc P, Le Noc D.
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
    Jones RN, Pfaller MA, Allen SD, Gerlach EH, Fuchs PC, Aldridge KE.
    Diagn Microbiol Infect Dis; 1991 May; 14(4):361-4. PubMed ID: 1889187
    [Abstract] [Full Text] [Related]

  • 5. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D.
    Rev Med Chir Soc Med Nat Iasi; 2003 May; 107(3):595-8. PubMed ID: 14756068
    [Abstract] [Full Text] [Related]

  • 6. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 7. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
    Bauernfeind A, Schweighart S, Eberlein E, Jungwirth R.
    Infection; 1991 Mar; 19 Suppl 5():S264-75. PubMed ID: 1664418
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Mar; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P, Gaillard JL.
    Ann Biol Clin (Paris); 1986 Mar; 44(6):624-7. PubMed ID: 3826779
    [Abstract] [Full Text] [Related]

  • 11. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P, Croize J, Le Noc D.
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [Abstract] [Full Text] [Related]

  • 12. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P, Oppenheim BA, Skepastianos P, Livermore DM, Williams RJ.
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
    Barry AL, Brown SD, Novick WJ.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 15. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 16. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC.
    Scand J Infect Dis Suppl; 1993 Sep; 91():25-32. PubMed ID: 8290900
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K, Inoue E, Mitsuhashi S.
    Chemotherapy; 1995 Sep; 41(4):257-66. PubMed ID: 7555206
    [Abstract] [Full Text] [Related]

  • 18. [In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals].
    Sader HS, Mendes CM, Montelli A, Sampaio J, Segura AJ, Kesselring GL, Costa L, Ribeiro JE, Mamizuka E, Mimiça I.
    Rev Assoc Med Bras (1992); 1998 Sep; 44(4):283-8. PubMed ID: 9852647
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.
    Liassine N, Bille J, Breer C, Frei R, Wüst J, Auckenthaler R.
    Scand J Infect Dis; 1997 Sep; 29(6):615-21. PubMed ID: 9571744
    [Abstract] [Full Text] [Related]

  • 20. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
    Neu HC, Chin NX, Labthavikul P.
    Infection; 1985 Sep; 13(3):146-55. PubMed ID: 3928497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.